Clinical Trial: A multicenter, prospective, observational real-world study of Etrasimod in the treatment of Chinese adult patients with moderate to severe active ulcerative colitis (China)

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, prospective, observational real-world study of Etrasimod in the treatment of Chinese adult patients with moderate to severe active ulcerative colitis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134156

Registration Time: 2026/10/11

Type: Observational study

Primary Sponsor: The First Affiliated Hospital of Sun Yat-Sen University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=277045

Published by HT Digital Content Services with permission from Health Daily Digest....